Crestchem has released its unaudited standalone financial results for the quarter and half-year ended September 30, 2025, revealing a mixed financial performance. The company's Board of Directors approved these results at a meeting held on November 12, 2025.

Financial Highlights

Key Points

• Revenue: The company reported revenue from operations of ₹30.75 for the quarter ended September 30, 2025.
• Profit Decline: Crestchem experienced a significant decrease in profit after tax for the half-year period, dropping from ₹365.68 in the previous year to ₹99.70.
• Asset Growth: Despite the profit decline, the company's total assets increased to ₹1,354.86, up from ₹1,054.49 in the previous period, indicating potential investments or acquisitions.
• Improved Liquidity: Cash and cash equivalents saw a notable increase, rising to ₹104.60 from ₹73.15, potentially strengthening the company's short-term financial position.

Corporate Governance

In line with regulatory requirements, Crestchem has implemented measures to ensure compliance with insider trading regulations:

• The trading window for company securities remains closed from July 1, 2025, until 48 hours after the public announcement of the financial results.
• This closure applies to directors, officers, key managerial personnel, and designated persons as defined under the company's internal code for prohibition of insider trading.

The financial results were approved at a board meeting that commenced at 12:30 PM and concluded at 4:00 PM on November 12, 2025. The company has submitted these results to the BSE Limited in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Investors and stakeholders should note that these are unaudited results and may be subject to review.

Crestchem Limited has announced key corporate developments following its recent board meeting. The company's Board of Directors convened on August 12, 2025, to review and approve financial results and make important personnel decisions.

Financial Results Approval

The board meeting, which commenced at 12:15 PM and concluded at 1:15 PM, saw the approval of unaudited standalone financial results for the quarter ended June 30, 2025. These results, prepared under Ind AS (Indian Accounting Standards), were accompanied by a limited review report in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

New Appointment

In a significant move, Crestchem Limited announced the appointment of Mr. Nitin S. Shah as the company's new Company Secretary, Compliance Officer, and Chief Financial Officer (CFO). Mr. Shah, who holds the ACS-7088 certification, assumed his new roles effective August 1, 2025. This appointment strengthens the company's leadership team and corporate governance structure.

Trading Window Closure

As part of its commitment to regulatory compliance, Crestchem Limited has implemented a trading window closure. This measure, in line with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code, affects directors, officers, key managerial personnel, and designated persons. The trading window has been closed from July 1, 2025, and will remain so until 48 hours after the public disclosure of the quarterly results.

Corporate Governance

The company's actions, including the timely approval of quarterly results and the appointment of key personnel, demonstrate its commitment to maintaining strong corporate governance practices. These steps are aimed at ensuring transparency and compliance with regulatory requirements.

Crestchem Limited, with its corporate office in Ahmedabad and registered office in Mehsana, Gujarat, continues to focus on its operations while adhering to regulatory norms and enhancing its management structure.

Investors and stakeholders are advised to refer to the detailed financial results and limited review report for a comprehensive understanding of the company's performance for the quarter ended June 30, 2025.